Keep it real
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And then another China threat is candy for the MM’s to push it extra lower with the general market going tits up.
Just remember that shorting has one goal: make money. Why do they do it? Because they can.
Yeah don't we all wish we sold at 9 and buy back now...
A very clinical, dry presentation so far
I suggest we discontinue this discussion as it doesn’t matter anymore. What’s done is done.
But would like to hear an explanation on Monday, but doubt we’ll get one.
There are no second chances in creating a first impression. The data has been framed by this dry, scientific abstract.
Well today didn’t really work out as planned. The predictions of the last few days have been pretty meaningless. Why add more credence to those about Monday?
As always, expectations were a lot higher.
When the dust settles, perhaps reality will kick in and it will be noticed that these results are a lot better then the current treatments.
Slow and steady.
Not quick and squeezy.
What’s the current rate? There must be quite some covering going on.
The data is encouraging. Let’s see what the company plans are on Monday.
Perhaps they can also explain today’s PR fuckup.
-13% premarket, FWIW
The results are encouraging but won’t trigger a short squeeze
I surely hope your prediction will become reality, but I have seen MM at work in a different stock and there it was brutally crushed, totally irrelevant of great trial results.
Fingers crossed.
Low volume is okay, this needs to cool down a bit to build a solid base for the next leg up.
Check out dark Pools Micro. Somehow MM’s always seem to get their way and retailers are fleeced.
Have seen this happen with other micro biotechs were shareprice gets hammered down upon good news.
Thanks for this insightful share price prediction. I find them always very useful.
Thanks. Just verifying with the group.
Do we know if Alex Trebek is taking our drug? Or just whishfull investor thinking?
No its not a good play: its a good investment.
What I meant is that having a shelf now says nothing about PC results.
The shelf says nothing about clinical results except “we need money in the future”.
Lots of investor confidence last 6 trading days!
How exciting! Truly valued by the market.
I know, but many seemed to disagree till today
Surprise! Biogen is not interested. MTA is over, well we figured that out a year ago.
Waiting for Rett ánd PDD data to partner means no public release of results as he will want those cards close to his chest. If the results are good.
thats 1% of todays trading volume, hardly worth calling that "getting in badly"
Nope, I do not need to cover
But I might sell some shares at $50.
If we get there. I can afford to lose this investment.
Awesome
Unfortunately prizes are only awarded at the end, not at launch.
I was continuing the analogy that Anavex has 3 rockets on the launchpad.
Some trials succeed, some trials fail.
So which one will be Challenger or Columbia ?
Oh dear Lord, I am totally excited by this gigantic reduction in short covering!
Thanks for the heads up. It’s been really helpfull in the past, deciding when to buy or dump shares.
Not sure. What if he subsequently would die? Not exactly great.
Did I predict doomsday?
I see this PR as a “have a look at me” now the general attention is drawn again on amyloid failure.
Trying to get some attention after BIIB’s failure?
Fully agree we needed new material. Have been waiting ages for Rett to start, especially as it is the shortest trial.
Oct17: All three trials initiating before end of the year.
Mar19: all three trials are actually initiated.
So, late? Yeah. But we got there. Eventually.
Great. We should be happy it finally happened.
Not quiet 2017 as promised, but hey who cares, its not like we are trying to make any money on this.